Tapolczay David 4
4 · CONDUIT PHARMACEUTICALS INC. · Filed Apr 24, 2024
Insider Transaction Report
Form 4
Tapolczay David
Director
Transactions
- Sale
Warrant (Right to buy)
2024-04-22−200,332→ 200,332 totalExercise: $3.12From: 2025-04-22Exp: 2027-04-22→ Common Stock (200,332 underlying) - Award
Warrant (Right to buy)
2024-04-22+400,664→ 400,664 totalExercise: $3.12From: 2025-04-22Exp: 2027-04-22→ Common Stock (400,664 underlying)
Footnotes (2)
- [F1]Warrants issued in exchange for one year lock-up of reporting person's common stock of the company, par value $0.0001 per share, and the payment of $0.125 per warrant.
- [F2]Warrants sold in exchange for $0.25 per warrant in private transaction.